Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Glenn David
Glenn David is recorded as CFO at Zoetis Inc. (ZTS). Zoetis Inc. reported in an 8-K filed February 7, 2023 that Glenn David was terminated as Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices, effective February 5, 2023. Zoetis Inc. reported in an 8-K filed October 25, 2022 that Glenn David was appointed Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices, effective November 1, 2022. The proxy statement of Zoetis Inc. reports total compensation of $3,672,350 for Glenn David in fiscal 2019, including a base salary of $690,000. Disclosed compensation is on record for 3 fiscal years. Glenn David has spoken on 4 earnings calls across 1 company, most recently for Zoetis Inc. on May 6, 2021.
“On February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc. (the "Company"), for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company.”
Zoetis Inc. Form 8-K, filed February 7, 2023
· Read the filing
“Zoetis Inc. (the "Company") appointed Glenn David as the Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices, effective November 1, 2022.”
Zoetis Inc. Form 8-K, filed October 25, 2022
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
